Wednesday October 24, 2012 0 comments
WESTMINSTER - Surefire Medical Inc. has received 510(k) FDA clearance to market its line of Surefire Angiographic Catheters, the company announced.
Surefire said the products will be released later this year.
Surefire said its catheter line is designed to provide interventional radiologists with greater flexibility and the highest level of trackability when performing infusion procedures.
The catheters will be available in a variety of curve styles for accessing a wide range of patient anatomies, the company said.
"Surefire designed our line of Angiographic Catheters to help advance interventional radiology procedures by providing optimal diagnostic imaging and detail during infusion procedures," said Jim Chomas, Surefire's CEO.
"We are excited to offer a suite of products to better meet their clinical needs. Further, the large inner lumen provides a new level of flexibility to these physicians."
It is the third FDA 510(k) clearance received by Surefire since July 2011. The company also received FDA 510(k) clearance for its Surefire Infusion System and Surefires's new ST and LT infusion systems.
In addition, Surefire received the CE Mark for the Surefire Infusion System in August.
For more information, visit www.surefiremedical.com.